Entropy Technologies LP Takes $3.63 Million Position in McKesson Corporation

The institutional investor purchased 4,695 shares of the pharmaceutical distribution company's stock.

Mar. 13, 2026 at 9:09am

Entropy Technologies LP, an institutional investor, purchased a new stake in shares of McKesson Corporation (NYSE:MCK) during the third quarter, according to its most recent 13F filing with the SEC. The investor acquired 4,695 shares of the company's stock, valued at approximately $3.63 million.

Why it matters

This investment by Entropy Technologies LP in McKesson Corporation, a major pharmaceutical distribution company, suggests the investor sees growth potential in the healthcare services and distribution sector. McKesson's stock performance and market position are closely watched by industry analysts as an indicator of broader trends in the pharmaceutical supply chain.

The details

According to the 13F filing, Entropy Technologies LP purchased 4,695 shares of McKesson Corporation, valued at approximately $3.63 million. McKesson is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and healthcare technology solutions.

  • The new stake was purchased during the third quarter of the reporting period.

The players

Entropy Technologies LP

An institutional investor that purchased a new stake in shares of McKesson Corporation.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and healthcare technology solutions.

Got photos? Submit your photos here. ›

The takeaway

This investment by Entropy Technologies LP in McKesson Corporation, a leading pharmaceutical distributor, suggests the investor sees growth potential in the healthcare services and distribution sector. The move reflects broader industry trends and investor interest in the pharmaceutical supply chain.